Renal Histology Findings in Malignant Hypertension, a Systematic Review

Valentin Maisons1,2, Ferhat Demir3, Alexandre Fillon1

  • 1Department of Nephrology (V.M., A.F., P.D., B.S., J.-M.H.), CHU de Tours, France.

PubMed
Abstract

Insights

Malignant hypertension often involves kidney damage beyond nephrosclerosis, with thrombotic microangiopathy prevalent in most patients. Understanding these renal histopathology findings is crucial for improving patient outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Pathology

Background:

  • Malignant hypertension (MH) causes severe target-organ damage, including kidneys.
  • Renal histopathology in MH is understudied due to bleeding risks associated with kidney biopsies.
  • The prevalence and characteristics of thrombotic microangiopathy in MH require further elucidation.

Purpose of the Study:

  • To systematically review and analyze renal histological findings in adult patients diagnosed with malignant hypertension.
  • To characterize the spectrum of kidney pathology associated with MH, with a focus on thrombotic microangiopathy.

Main Methods:

  • A systematic review adhering to PRISMA guidelines was conducted.
  • Searches were performed across major databases (PubMed, Embase, Cochrane Library, Web of Science).
  • Data on demographics, clinical presentation, and renal histology were extracted from eligible studies.

Main Results:

  • The analysis included 1781 patients from 144 studies, predominantly male (67%), with a mean age of 38.4 years.
  • Elevated serum creatinine (587.8 µmol/L) and proteinuria (4.3 g/g) were observed.
  • Nephrosclerosis was found in 68.4%, while thrombotic microangiopathy was highly prevalent (hematologic: 72.8%, renal: 95.2%), with increasing rates over time.

Conclusions:

  • A significant proportion of MH patients exhibit renal lesions beyond simple nephrosclerosis.
  • Hematologic and renal thrombotic microangiopathy are common in malignant hypertension, affecting two-thirds and nearly all patients, respectively.
  • Further research into complement pathways is recommended for improved prognosis and therapeutic strategies.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
457
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
770
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
726
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K